Scoping review synthesizes evidence on lenacapavir efficacy and safety in diverse healthcare settings, highlighting implications for adoption.
Despite these promising developments, important questions remain regarding the implementation, accessibility, acceptability, safety, cost-effectiveness, and long-term effectiveness of lenacapavir across different populations and healthcare settings. Concerns related to affordability, healthcare infrastructure, insurance coverage, and equitable global access may influence the widespread adoption of this novel intervention. Aim: This scoping review aims to synthesize current evidence on the efficacy, safety, acceptability, implementation, and equity dimensions of lenacapavir as a long-acting, twice-yearly injectable for HIV prevention.
No takes yet. Share an insight, caveat, or question.
Stanley Chinedu Eneh (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: